🔎 Trials Near Me

Akèy › Karsinòm selil skuamèz tèt ak kou › Nebraska › Omaha

Etid klinik pou Karsinòm selil skuamèz tèt ak kou nan Omaha, NE

13 etid pou Karsinòm selil skuamèz tèt ak kou ap chèche patisipan nan sit nan ak bò kote Omaha (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Ap rekriteFaz 3
  • Nebraska Medicine-Village Pointe, Omaha
  • University of Nebraska Medical Center, Omaha
  • Nebraska Medicine-Bellevue, Bellevue · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06992427

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Ap rekriteFaz 1
  • Exelixis Clinical Site #2, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05176483

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Nebraska Cancer Specialists, Omaha
  • XCancer, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07189871

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Ap rekriteFaz 2
  • Nebraska Medicine-Village Pointe, Omaha
  • University of Nebraska Medical Center, Omaha
  • Nebraska Medicine-Bellevue, Bellevue · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05136196

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Ap rekriteFaz 2
  • Nebraska Methodist Hospital, Omaha
  • Heartland Oncology and Hematology LLP, Council Bluffs · 4 mi lwen
  • Methodist Jennie Edmundson Hospital, Council Bluffs · 4 mi lwen
Laj 18 a 79 · Tout sèks · Mizajou Sep 22, 2026 · NCT04671667

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Ap rekriteFaz 1/2
  • Nebraska Cancer Specialists, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07109726

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Ap rekriteFaz 2
  • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
  • Nebraska Methodist Hospital, Omaha
  • Alegent Health Immanuel Medical Center, Omaha
  • ak 5 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT02734537

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Ap rekriteFaz 2
  • Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT06769698

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Ap rekriteFaz 2/3
  • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
  • Nebraska Methodist Hospital, Omaha
  • Heartland Oncology and Hematology LLP, Council Bluffs · 4 mi lwen
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT04333537

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Ap rekriteFaz 1/2
  • Nebraska Cancer Specialists, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT04198766

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

Ap rekriteFaz 3
  • GSK Investigational Site, Omaha
Laj 18 ak plis · Tout sèks · Mizajou May 26, 2026 · NCT06256588

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Nebraska Cancer Specialists, Omaha
Laj 18 ak plis · Tout sèks · Mizajou Feb 18, 2026 · NCT07030257

Etid Karsinòm selil skuamèz tèt ak kou nan lòt vil

Lòt etid nan Omaha

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.